A Phase 1, Randomized, Open-Label, Single-Dose, 3-Way Crossover Study to Assess the Relative Bioavailability of a TAK-648 Tablet Compared With a TAK-648 Oral Solution, and to Assess the Effect of Food on the Bioavailability of a TAK-648 Tablet in Healthy Participants
Phase of Trial: Phase I
Latest Information Update: 19 Sep 2016
At a glance
- Drugs TAK 648 (Primary) ; TAK 648
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Takeda
- 29 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Aug 2015 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 27 Jun 2015 New trial record